Galera Therapeutics, INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
OQB
Ikarian Capital, LLC and Neil Shahrestani have reported a complete divestment of their holdings in Galera Therapeutics, Inc., indicating a significant shift in their investment strategy.
OQB
Investment firm Ikarian Capital, LLC and Neil Shahrestani have jointly disclosed a 9.99% beneficial ownership stake in Galera Therapeutics, Inc., holding 7,538,690 shares of common stock as of December 31, 2024.